Robin R. Frey
AbbVie (United States)(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours(2017)825 cited
- → Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors(2005)152 cited
- → Trifluoromethyl ketones as inhibitors of histone deacetylase(2002)147 cited
- → Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor(2020)127 cited
- → Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)(2002)113 cited
- → α-Keto amides as inhibitors of histone deacetylase(2003)81 cited
- → Differential protein acetylation induced by novel histone deacetylase inhibitors(2004)67 cited
- → Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors(2017)64 cited
- → Heterocyclic ketones as inhibitors of histone deacetylase(2003)52 cited
- → Design, Synthesis, and Evaluation of Matrix Metalloprotease Inhibitors Bearing Cyclopropane-Derived Peptidomimetics as P1‘ and P2‘ Replacements(2002)49 cited